Asymmetric ligand recognition by the activating natural killer cell receptor NKG2D, a symmetric homodimer
about
Commentary on CAM and NK Cells by Kazuyoshi Takeda and Ko OkumuraCrystal Structure of the Cowpox Virus-Encoded NKG2D Ligand OMCPIn vivo expression pattern of MICA and MICB and its relevance to auto-immunity and cancerThe SCHOOL of nature: I. Transmembrane signaling.The NKG2D ligands RAE-1δ and RAE-1ε differ with respect to their receptor affinity, expression profiles and transcriptional regulation.NKG2D ligands: unconventional MHC class I-like molecules exploited by viruses and cancer.The SCHOOL of nature: III. From mechanistic understanding to novel therapiesGlycosylation contributes to variability in expression of murine cytomegalovirus m157 and enhances stability of interaction with the NK-cell receptor Ly49H.Structural biology of shared cytokine receptors.NKG2D ligands in tumor immunity.Cytomegalovirus microRNAsAlternative Splice Transcripts for MHC Class I-like MICA Encode Novel NKG2D Ligands with Agonist or Antagonist Functions.Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors.Obstructing shedding of the immunostimulatory MHC class I chain-related gene B prevents tumor formation.NKG2D homodimer interacting with ligandsThe Biological Influence and Clinical Relevance of Polymorphism Within the NKG2D LigandsCatch us if you can
P2860
Q24799003-7570D66E-198E-47E4-8C9B-241681682A12Q27674864-74123271-36CC-4342-8BAB-94B98018C60BQ33287471-C0E2CE02-FBFC-4FC0-8156-BF161D398D98Q33351190-D56FEE30-9C65-4B8F-AB65-C7DEB7B51676Q33728181-5B782B3F-9F8E-488D-9F6C-BF906FC26FCFQ34197825-1FFF8651-C694-4D80-9CF9-B7E80D70AE80Q34619705-11E9DCE1-9412-4DE7-A897-1BB63F1A3484Q34759678-D80BF0C2-28A7-46E0-BBDD-C9DFEC62825CQ37279324-9728C885-79E7-406E-8948-A88C21542433Q37287179-E0BA27B7-3ECF-4C28-BAF6-08A6F649447BQ38207407-29E691CD-6EAF-40F1-9DA5-5E5D6B0F24B4Q38762336-32D34616-2DFA-4A72-A9BF-F7D05EAE7570Q38860610-23B6F481-2813-4E65-BACC-BF24CBA69EC1Q39894593-1B4F1BFC-BAD5-43BD-BCAE-4AED81F2857BQ50291603-4317C5BA-C779-4834-B957-47B454D5B912Q58773661-9F76F6A0-F329-42C4-A059-7326033E1E88Q59032647-881BA855-B208-4A08-BC52-69136F3D1549
P2860
Asymmetric ligand recognition by the activating natural killer cell receptor NKG2D, a symmetric homodimer
description
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im Mai 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/05/01)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/05/01)
@nl
наукова стаття, опублікована в травні 2002
@uk
مقالة علمية (نشرت في مايو 2002)
@ar
name
Asymmetric ligand recognition ...... r NKG2D, a symmetric homodimer
@ast
Asymmetric ligand recognition ...... r NKG2D, a symmetric homodimer
@en
Asymmetric ligand recognition ...... r NKG2D, a symmetric homodimer
@nl
type
label
Asymmetric ligand recognition ...... r NKG2D, a symmetric homodimer
@ast
Asymmetric ligand recognition ...... r NKG2D, a symmetric homodimer
@en
Asymmetric ligand recognition ...... r NKG2D, a symmetric homodimer
@nl
prefLabel
Asymmetric ligand recognition ...... r NKG2D, a symmetric homodimer
@ast
Asymmetric ligand recognition ...... r NKG2D, a symmetric homodimer
@en
Asymmetric ligand recognition ...... r NKG2D, a symmetric homodimer
@nl
P1433
P1476
Asymmetric ligand recognition ...... r NKG2D, a symmetric homodimer
@en
P2093
Roland K. Strong
P304
P356
10.1016/S0161-5890(02)00032-9
P577
2002-05-01T00:00:00Z